Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fusion Fuel Releases Investor Update Video and Investor Presentation
-
HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
-
VenHub Opens Second, Larger Las Vegas Production Facility
-
Clearsense Launches Managed Service for Continuous Application Rationalization and Active Archiving
-
Civinity to present bond issue to investors
-
Burns & Wilcox Global Solutions Goes Live with Novidea Insurance Management Platform to Drive Global-to-London Market Operations
-
Allot to Meet Investors at the 46th Annual William Blair Growth Stock Conference on June 2, 2026
-
Burns & Wilcox Global Solutions Goes Live with Novidea Insurance Management Platform to Drive Global-to-London Market Operations
-
Lawrencetown, N.S. resident wins Trucks for Ducks grand prize, driving support for Ducks Unlimited Canada’s wetland conservation
-
Avis Budget Group Announces Intention to Offer $300 Million of Senior Notes
-
Abercrombie & Fitch Co. Reports First Quarter Fiscal 2026 Results
-
Q2 Metals Announces 2026 Summer Exploration Program and Project Development Plans for the Cisco Lithium Project
-
Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043
-
Charles IT Named a 2026 Best and Brightest Company to Work For® Nationally and in New England
-
Papa Johns Teams Up with Disney and Pixar for the Release of Toy Story 5
-
TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial
-
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease
-
Anterix Names Kim Green-Kerr as Chief Revenue Officer to Accelerate Private Network Growth
-
Morocco Strategic Minerals Corp. Enters Agreement to Sell Sakami Property in Québec
-
SOLOWIN HOLDINGS (AXG) Announces AX Coin’s MOU with The BENEFIT Company to Explore Stablecoin Applications
-
Streamex Corp. and Orca Announce Launch of 24/7 Decentralized Secondary Liquidity Infrastructure for Tokenized Securities; GLDY the Inaugural Asset
-
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
-
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
-
Medline announces participation in upcoming investor conferences
-
Abundia Global Impact Group Provides Business Update Demonstrating Execution in Commercialization Strategy
-
Abercrombie & Fitch Co. Reports First Quarter Fiscal 2026 Results
-
Transforming Rural Health Care Through a First-of-its-Kind Collaborative
-
FTI Consulting Grows Transactions Practice With Appointment of Damon Yousefy as Senior Managing Director
-
Quantum Cyber Files Provisional Patent Application for Coaxial Dual-Propellant Grain Solid Rocket Motor Designed to Extend Range and Loiter Time of Defense UAVs
-
HNL Lab Medicine Receives Accreditation from the College of American Pathologists
-
Goliath Resources Mobilizes For A Fully Funded 50,000 Meter Expansion Drill Program On Surebet Discovery, Golden Triangle, B.C.
-
Man Group PLC : Form 8.3 - Bodycote Plc
-
Man Group PLC : Form 8.3 - AMG Critical Materials N.V
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics
-
Man Group PLC : Form 8.3 - A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Dr. Coffee Formally Partners with Mixue Bingcheng to Deliver Standardized Smart Coffee Solutions at Scale
-
Man Group PLC : Form 8.3 - DCC Plc
-
TransUnion Named One of America’s Most Trustworthy Companies 2026 by Newsweek
-
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
-
Erdene Releases 2026 Shareholder Letter and Provides Investor Update Webcast
-
Major Drilling to Release Results for its Fourth Fiscal Quarter and Fiscal 2026 on Wednesday, June 10, 2026
-
Invivyd to Participate in Upcoming Investor Events
-
Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology
-
Synack Named a Leader in G2’s Grid Report and Enterprise Grid Report for Penetration Testing, Summer 2026
-
Wevr and HTC Announce The Blu: Expedition Taiwan, First in Global Series of Immersive Ocean XR Experiences
-
Argo Provides Update on Patent Filings for Smart Routing™ Technology
-
X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
-
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
-
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

